News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Janssen Pharmaceutical K.K. Opens R&D Center in Shanghai



2/6/2013 10:21:08 AM

by Richard Daverman, PhD and Henry Ye

February 5, 2013 -- Janssen Pharmaceutical, a division of Johnson & Johnson, has officially opened its China R&D Center in Shanghai Fenglin Life Science Park. The lab is located in the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. It will collaborate with the SIOC, Fudan University School of Medicine and other institutions to conduct research into three major disease areas: immunology, oncology and infectious disease. More details....

Stock Symbol: (NYSE: JNJ)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES